Related Experiment Video
Updated: Jun 23, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
Published on: December 11, 2016
White paper. The five myths of generic competition. A Pharma Matters report. March 2009
Abstract:
A unique, wide-ranging survey of originator pharmaceutical companies by Thomson Reuters found that commercial professionals either consider there is nothing they can do to prevent sales erosion by generic drugs, or assume that the problem is being dealt with by somebody else in their organization. In this white paper, Thomson Reuters exposes these and other myths about generic competition, and shows what originators can do to predict its likely timing, source, and intensity.
Related Concept Videos
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
Pharmaceutical Equivalents
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
Formulation and Manufacturing Process: Physical Attributes of Generic Tablets and Capsules
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Drug Products: Biologics, Biosimilars and Interchangeables

